The effects of medications on circulating levels of cardiac natriuretic peptides
about
Ivabradine, coronary artery disease, and heart failure: beyond rhythm controlEffect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysisDiagnostic accuracy of plasma NT-proBNP levels for excluding cardiac abnormalities in the very elderly.Association of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients.Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes.Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster.Does B-type natriuretic peptide-guided therapy improve outcomes in patients with chronic heart failure? A systematic review and meta-analysis of randomized controlled trials.Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care.Future of personalized pharmacotherapy in chronic heart failure patients.Tailored therapy for heart failure: neurohormones.Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure.Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure.Early NT-proBNP decrease with ivabradine in ambulatory patients with systolic heart failure.Effects of dihydralazine on renal water and aquaporin-2 excretion in humans.B-type natriuretic peptide or amino-terminal pro-B-type natriuretic peptide-guided treatment of heart failure: what is the next STEP?Biological, electrical and echocardiographic indices versus cardiac magnetic resonance imaging in diagnosing left ventricular hypertrophy.
P2860
Q26865770-9D4A567B-C22E-464B-A4FF-8FAB335829C9Q27012693-DCB0133C-193F-4AA3-9E84-0F8C30A5C1D7Q33744529-0DCE411D-2A1C-4FFA-B71B-1B1F557D7E4AQ34352658-111A7A61-1DBF-483D-AA00-5AD87CD514D5Q34477882-30207771-DC4D-4560-99D2-9CE6C113FB78Q34718106-F36C2E7D-50E0-4AEE-8A00-304C9A708346Q35179984-D0370CA3-7604-4EB1-B9CC-31EF248104DBQ37092258-F0D3DE29-460F-467F-8C13-185053A7F6BFQ37762320-A6E3DB9B-BA2B-4196-BFBD-20911EE2539EQ37882710-EE670364-4E84-4F60-B751-ECCB4886D7E9Q37910927-F0A84971-43C3-4189-908C-296832DFBB31Q37980254-C7F29034-7023-4B54-AEFC-52268E185C36Q45945713-A93E26F4-9350-4D9D-A082-7F30036B0C68Q46277332-B8A416A2-4451-4D57-8CF7-8915303F843BQ46409881-A7C6E96F-0DE0-46FA-8598-FF415CF590D2Q48930054-931FEF69-DB84-42BC-8D96-B26A7811FC51Q48930338-F9D2130C-9F42-42BC-A7A9-05239F62DAC0
P2860
The effects of medications on circulating levels of cardiac natriuretic peptides
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The effects of medications on circulating levels of cardiac natriuretic peptides
@ast
The effects of medications on circulating levels of cardiac natriuretic peptides
@en
The effects of medications on circulating levels of cardiac natriuretic peptides
@nl
type
label
The effects of medications on circulating levels of cardiac natriuretic peptides
@ast
The effects of medications on circulating levels of cardiac natriuretic peptides
@en
The effects of medications on circulating levels of cardiac natriuretic peptides
@nl
prefLabel
The effects of medications on circulating levels of cardiac natriuretic peptides
@ast
The effects of medications on circulating levels of cardiac natriuretic peptides
@en
The effects of medications on circulating levels of cardiac natriuretic peptides
@nl
P2093
P2860
P1433
P1476
The effects of medications on circulating levels of cardiac natriuretic peptides
@en
P2093
A Mark Richards
Chris M Frampton
M Gary Nicholls
Richard W Troughton
Tim G Yandle
P2860
P304
P356
10.1080/07853890701232057
P407
P577
2007-01-01T00:00:00Z